Are Cytokines Possible Mediators of Cancer Cachexia?

Surgery Today

Volumn 26, Issue 7, 1996, Pages 467-475

  Noguchi, Yoshikazu ^a   Yoshikawa, Takaki ^a   Matsumoto, Akihiko ^a   Svaninger, Gösta ^b   Gelin, Johan ^b  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cancer cachexia; Interferon gamma; Interleukin 1; Interleukin 6; Tumor necrosis factor alpha

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 6; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

CACHEXIA; HUMAN; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

CACHEXIA; CYTOKINES; DINOPROSTONE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-6; NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029681746     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00311551     Document Type: Review

References (82)

1. Moldawer LL, Andersson C, Gelin J, Lundholm KG (1988) Regulation of food intake and hepatic protein synthesis by recombinant-derived cytokines. Am J Physiol 254:450-456
2. Norton JA, Moley JF, Green MV, Carson RE, Morrison SD (1985) Parabiotic transfer of cancer anorexia/cachexia in male rats. Cancer Res 45:5547-5552
3. Sherry BA, Gelin J, Fong Y, Marano M, Wei H, Cerami A, Lowry SF, Lundholm KG, Moldauer LL (1989) Anticachectin/tumor necrosis factor-alpha antibodies attenuated development of cachexia in tumor models. FASEB J 3:1956-1962
4. Old LJ (1985) Tumor necrosis factor (TNF). Science 230:641-644
5. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666-3670
6. 2 and cAMP. J Immunol 141:587-591
7. Oliff A (1988) The role of tumor necrosis factor (cachectin) in cachexia. Cell 54:141-142
8. Beutler B, Cerami A (1986a) Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature 320:584-588
9. Flick O, Gifford G (1986) Pharmacokinetics of murine tumor necrosis factor. J Immunopharmacol 8:89-97
10. Sugarman BJ, Aggarwal BB, Hass PE, Figart IS, Pallladon Jr MA, Shepard HM (1985) Recombinant human tumor necrosis factor-alpha: Effects on proliferation of normal and transformed cells in vitro. Science 230:943-945
11. Van Damme J, Opdenakker G, Simpson RJ, Rubira MR, Cayphas S, Vink A, Billan A, Van Snick J (1987) Identification of the human 26-KD protein, interferon beta-2 (IFN beta-2), as B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor. J Exp Med 165:914-919
12. Leibovich SJ, Polverinio PJ, Shepard HM, Wisoman DM, Shively V, Nuseir N (1987) Macrophage-induced angiogenesis is mediated by tumor-necrosis factor-alpha. Nature 329:630-632
13. Mahony SM, Tisdale MJ (1989) Role of prostaglandins in tumor necrosis factor induced weight loss. Br J Cancer 60:51-55
14. Michie HR, Sherman ML, Spriggs DR, Christie RJ, Wilmore DW (1989) Chronic TNF infusion causes anemia and not accelerated nitrogen loss. Ann Surg 104:280-286
15. Darling G, Fraker DL, Jensen JC, Gorschboth CM, Norton JA (1990) Cachectic effects of recombinant tumor necrosis factor in rats. Cancer Res 50:4008-4013
16. Norton JA (1991) Mechanisms of cancer cachexia. Hematol Oncol Clin North Am 103-123
17. Mahony SM, Tisdale MJ (1988) Induction of weight loss and metabolic alterations by human recombinant tumor necrosis factor. Br J Cancer 58:345-349
18. Kawakami M, Cerami A (1981) Studies of endotoxin-induced decrease in lipoprotein lipase activity. J Exp Med 154:631-637
19. Feingold KR, Grunfeld C (1987) Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vitro. J Clin Invest 80:184-190
20. Oliff A, Defeo-Jones D, Boyer M, Martinez D, Kiefer D, Vuocolo G, Wolfe A, Socher SH (1987) Tumor secreting human TNF-cachectin induced cachexia in mice. Cell 50:555-563
21. Stovroff ML, Fraker DL, Norton JA (1989) Cachectin activity in the serum of cachectic, tumor-bearing rats. Arch Surg 124:94-99
22. Lönnroth C, Moldauer LL, Gelin J, Kindholm L-G, Sherry B, Lundholm K (1990) Tumor necrosis factor and interleukin 1 alpha production in cachectic, tumor-bearing mice. Int J Cancer 46:889-896
23. Fulton AM (1988) Inhibition of experimental metastasis with indomethacin: role of macrophages and natural killer cells. Prostaglandins 35:413-425
24. Balkwill F, Burk F, Talbert D, Tavernier J, Osborne R, Naylor S, Durbin H, Fiers W (1987) Evidence for tumor necrosis factor-cachectin production in cancer. Lancet ii:1229-1232
25. Aderka D, Fisher S, Levo Y, Holtmann H, Hahn T, Wallach D (1987) Cachectin: tumor necrosis factor production by cancer patients. Lancet ii:1190
26. Moldawer L, Drott C, Lundholm K (1988) Monocytic production and plasma bioactivities of interleukin-1 and tumor necrosis factor in human cancer. Eur J Clin Invest 18:486-492
27. Socher SH, Martinez D, Craig JB, Kahn JG, Oliff A (1988). Tumor necrosis factor not detectable in patients with clinical cachexia. J Natl Cancer Inst 80:595-598
28. Mulligan HD, Mahony SM, Ross JA, Tisdale MJ (1992) Weight loss in a murine cachexia model is not associated with the cytokine tumour necrosis factor-alpha or interleukin-6. Cancer Lett 65:239-243
29. Sheppard BC, Venzon D, Fraker DL, Langstein HN, Jensen JC, Norton JA (1990) Prolonged survival of tumor-bearing rats with repetitive low-dose recombinant tumor necrosis factor. Cancer Res 50:3928-3933
30. Naylor MS, Stamp GWH, Balkwill FR (1990) Investigation of cytokine gene expression in human colorectal cancer. Cancer Res 50:4436-4440
31. 3 terminal sequence of a plasmacytoma growth factor derived from the murine macrophage cell line P388D1. J Immunol 139: 813-817
32. Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Masuda T, Kashiwamura S, Nakajima K, Koyama K, Iwamatsu A, Tsunagawa S, Shikiyama F, Masui H, Takahara Y, Taniguchi T, Kishimoto T (1986) Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324:73-76
33. Schreiber G, Tsyklin A, Aldred AR, Thomas T, Fung WP, Dickson PW, Cole T, Birch H, De JF, Milland J (1989) The acute phase response in the rodent. Ann NY Acad Sci 557:61-85
34. Bladel AV, Libert C, Fiers W (1991) Interleukin-6 enhances the expression of tumor necrosis factor receptors on hepatoma cells and hepatocytes. Cytokine 3:149-154
35. Strassmann G, Fong M, Keny JS, Jacob CO (1992) Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 89:1681-1684
36. Black K, Garrett IR, Mundy GR (1991) Chinese hamster ovarian cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude mice. Endocrinology 128:2657-2659
37. Greenberg AS, Nordan RP, McIntosh J, Calvo JC, Scow RD, Jablons D (1992) Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia. Cancer Res 52:4113-4116
38. Tabibzadeh SS, Poubouridis AB, May LT, Sehgal PB (1989) Interleukin-6 immunoreactivity in human tumors. Am J Pathol 135:427-433
39. Monti G, Jauraud MC, Monnet I, Chrétien P, Saint-Etienne L, Zeng L, Portier A, Deviller P, Galanaud P, Bignon J, Emilie D (1994) Intrapleural production of interleukin 6 during mesothelioma and its modulation by gamma-interferon treatment. Cancer Res 54:4419-4423
40. Yoneda T, Nakai M, Moriyama K, Scott L, Ida N, Kunitomo T, Mundy GR (1993) Neutralizing antibodies to human interleukin 6 reverse hypercalcemia associated with a human squamous carcinoma. Cancer Res 53:737-740
41. Starnes HF, Warren RS, Jeevanandam M, Gabrilove JL, Larchian W, Oettgen HF, Brennan MF (1988) Tumor necrosis factor and acute metabolic response to tissue injury in man. J Clin Invest 82:1321-1325
42. Fong Y, Moldawer LL, Marano M, Wei H, Barber A, Manogue K, Tracey KJ, Kuo G, Fishman DA, Cerami A, Lowry SF (1989) Cachectin/TNF of IL-1 alpha induces cachexia with redistribution of body proteins. Am J Physiol 256:R659-R665
43. Belizario JE, Matz M, Chenker E, Raw I (1991) Bioactivity of skeletal muscle proteolysis-inducing factors in the plasma proteins from cancer patients with weight loss. Br J Cancer 63:705-710
44. Mrosovsky N, Molony LA, Conn LA, Kluger MJ (1989) Anorexic effects of interleukin 1 in the rat. Am J Physiol 257:R1315-1321
45. Murray MJ, Murray AB (1979) Anorexia of infection as a mechanisms of host defense. Am J Clin Nutr 32:593-596
46. Hoffman-Goetz L, McFarlane P, Bistrian BR, Blackburn GL (1981) Febrile and plasma iron responses to rabbits injected with endogenous pyrogens from malnourished patients. Am J Clin Nutr 34:1109-1116
47. Gelin J, Moldwer LL, Lönnroth C, Sherry B, Chizzonite R, Lundholm K (1991) Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia. Cancer Res 51:415-421
48. Strassmann G, Masui Y, Chizzonite R, Fong M (1993) Mechanisms of experimental cancer cachexia. J Immunol 150:2341-2345
49. Strassmann G, Jacob CO, Evans R, Beall D, Fong M (1992) Mechanisms of experimental cancer cachexia. J Immunol 148: 3674-3678
50. Langstein HN Norton JA (1991) Mechanisms of cancer cachexia. Hematol Oncol Clin North Am 5:103-123
51. Langstein HN, Doherty GM, Fraker DL, Buresh CM, Norton JA (1991) The roles of gamma-interferon and tumor necrosis factor alpha in an experimental rat model of cancer cachexia. Cancer Res 51:2302-2306
52. Matthys P, Heremans H, Opdenakker G, Billian A (1991) Anti-interferon-gamma antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexia. Eur J Cancer 27:182-187
53. Matthys P, Dijkmans R, Proost P, Damme JV, Heremans H, Sobis H, Billiau A (1991) Severe cachexia in mice inoculated with interferon-gamma-producing tumor cells. Int J Cancer 49:77-82
54. Kawakami M, Kondo Y, Imai Y, Hashiguchi M, Ogawa H, Hiragun A, Aotsuka S, Shibata S, Oda T, Murase T, Takaku F (1991) Suppression of lipoprotein lipase in 3T3-L1 cells by a mediator produced by SEKI melanoma, a cachexia-inducing human melanoma cell line. J Biochem 109:78-82
55. Michie HR, Guillou PJ, Wilmore DW (1989) Tumor necrosis factor and bacterial sepsis. Br J Surg 76:670-671
56. Moldawer LL, Georgieff MM, Lundholm K (1987) Interleukin-1, tumor necrosis factor-alpha (cachectin) and the pathogenesis of cancer cachexia. Clin Physiol 7:263-274
57. Dinarello CA, Bernheim HA (1981) Ability of human leukocytic pyrogen to stimulate brain prostaglandin synthesis in vitro. J Neurochem 37:702-708
58. Callery MP, Mangino MJ, Kamei T, Flye MW (1990) Interleukin-6 production by endotoxin-stimulated kupffer cells is regulated by prostaglandin E2. J Surg Res 48:523-527
59. Endres S, Ghorbani R, Kelly VE, Georgilis K, Lonnemann G, Van Der Meer JWM, Cannon JG, Rogers TS, Klempner MS, Weber PC, Schaefer EJ, Wolff SM, Dinarells CA (1989) The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 320:256-271
60. Godfrey RW, Johnson WJ, Hoffstein ST (1987) Recombinant tumor necrosis factor and interleukin-1 both stimulate human synovial cell arachidonic acid release and phospholipid metabolism. Biochem Biophys Res Comm 142:235-241
61. 2 regulates macrophage-derived tumour necrosis factor gene expression. J Biol Chem 263:5380-5384
62. Stausser HR, Humes JL (1975) Prostaglandin synthesis inhibition: Effects on the bone change and sarcoma tumor induction in BALB/c mice. Int J Cancer 15:724
63. Hubbard NE, Chapkin RS, Erickson KL (1988) Inhibition of growth and linoleate-enhanced metastasis of a transplantable mouse mammary tumor by indomethacin. Cancer Lett 43:111
64. Gelin J (1990) Cancer cachexia. An experimental study with special reference to cytokines as endogenous mediators. Doctor's thesis, Göteborg University, Göteborg, pp 1-74
65. Fulton AM (1988) Inhibition of experimental metastasis with indomethacin: Role of macrophages and natural killer cells. Prostaglandins 35:413-425
66. Milas L, Furuta Y, Hunter N, Nishiguchi I, Runkel S (1990) Dependence of indomethacin-induced potentiation of murine tumor radioresponse on tumor host immunocompetence. Cancer Res 50:4473-4477
67. Folkman J (1986) How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes Memorial Award Lecture. Cancer Res 46:467
68. Tanaka Y, Tanaka T, Ishitsuka H (1989) Antitumor activity of indomethacin in mice bearing advanced colon 26 carcinoma compared with those with early transplants. Cancer Res 49:5935-5939
69. Gelin J, Andersson C, Lundholm K (1991) Effects of indomethacin, cytokines, and cyclosporin A on tumor growth and the subsequent development of cancer cachexia. Cancer Res 51:880-885
70. Karmali Ra, Welt S, Thaler HT, Lefevre F (1983). Prostaglandins in breast cancer: Relationship to disease stage and hormone status. Br J Cancer 48:689-696
71. Michie HR, Guillou PJ, Wilmorem DW (1989) Tumour necrosis factor and bacterial sepsis. Br J Surg 76:670-671
72. Grau G, Taylor T, Trop M, Molyneux ME, Wirima JJ, Vassalli P, Hommel M, Lambert PH (1989) Tumor necrosis factor and disease in children with falciparum malaria. N Engl J Med 320:1586-1598
73. Socher SH, Martinez D, Craig JB, Kuhn JG, Oliff A (1988) Tumor necrosis factor not detectable in patients with clinical cancer cachexia. J Natl Cancer Inst 80:595-598
74. Siimes MA, Toppo AM, Koskelo EK, Saarinen UM (1991) Serum tumor necrosis factor does not correlate with changes in muscle volume in children with malignancies. Pediatr Hematol Oncol 8:69-75
75. Cerami A (1992) Inflammatory cytokines. Clin Immunol Immunopathol 62:S3-S10
76. Balkwill FR, Burk F (1989) The cytokine network. Immunol Today 10:299-303
77. Michie HR, Manogue KA, Spriggs DR, Revhaug A, O'Dwyer S, Dinarello LA, Cerami A, Wolff SM, Wilmore DW (1988) Detection of tumor necrosis factor after endotoxin administration. N Engl J Med 318:1481-1486
78. Kettlehut IC, Fiers W, Goldberg AL (1987) The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors. Proc Natl Acad Sci USA 84:4273-4277
79. McNamara MJ, Alexander HR, Norton JA (1992) Cytokines and their role in the pathophysiology of cancer cachexia. JPEN 16:50s-55s
80. Tessitore L, Costelli P, Baccino FM (1993) Humoral mediation for cachexia in tumor-bearing rats. Br J Cancer 67:15-23
81. Mori M, Yamaguchi K, Honda S, Nagasaki K, Ueda M, Abe O, Abe K (1991) Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor. Cancer Res 51:6656-6659
82. Ardizzoia A, Lissoni P, Brivis F, Tisi E, Perego MS, Grassi MG, Pittalis S, Crispino S, Barni S, Tancini G (1992) Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease. J Biol Regul Homeost Agents 6:103-107